This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Zhaojun Ren: Innovator in Phage Display Technology
Introduction
Zhaojun Ren is a prominent inventor based in Elkridge, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of phage display systems. His innovative work has the potential to impact various medical applications, including immunization and treatment of disorders.
Latest Patents
Zhaojun Ren holds a patent for "Phage display of intact domains at high copy number." This patent discloses a phage display system where molecules of interest are bound to dispensable capsid polypeptides, such as SOC (small outer capsid) and HOC (highly antigenic outer capsid) polypeptides. These are further bound to a surface lattice protein found on virions or polyheads. The patent also outlines methods for displaying a molecule of interest, immunizing patients through displayed antigens, and treating patients with disorders linked to aberrant biological molecules. He has 1 patent to his name.
Career Highlights
Zhaojun Ren is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution allows him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Zhaojun Ren's notable coworkers include Alasdair C Steven and Paul T Wingfield. Their collaborative efforts enhance the research environment and foster innovation in biotechnology.
Conclusion
Zhaojun Ren's contributions to phage display technology exemplify the intersection of innovation and medical application. His work not only advances scientific understanding but also holds promise for future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
